Rare diseases
Investigational molecules
Locations
Back to Spain53 clinical trials in La Laguna, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
SpainStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
SpainLong-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria
SpainStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
SpainStudy Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib
SpainStudy on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)
SpainStudy of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
SpainStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
SpainStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
SpainStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
SpainStudy of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer
SpainStudy on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on breast cancer treatments, including studies of novel therapies for both HER2-positive and HR-positive variants. Research includes innovative approaches for metastatic sarcomas and lymphoma treatments.
Multiple studies evaluating targeted therapies and immunotherapies for various cancer types.
Clinical investigations examining treatments for severe asthma, allergic rhinitis, and autoimmune conditions like Sjögren's syndrome and systemic lupus erythematosus.
Focus on developing targeted immunotherapies and evaluating long-term treatment outcomes.
Studies investigating metabolic syndrome management in kidney transplant candidates and innovative approaches to prevent post-transplant diabetes. Research includes evaluation of GLP-1 receptor agonists.
Comprehensive research aimed at improving transplant outcomes and metabolic health.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
